Tomography, Emission-Computed

• 

  Subject Areas on Research

  • (18)F-fluorodeoxyglucose positron emission tomography and MR imaging findings in Rasmussen encephalitis. 
  • (4-[18F]fluoro-3-iodobenzyl)guanidine, a potential MIBG analogue for positron emission tomography. 
  • 18-Fluorodeoxyglucose positron emission tomography in children and adolescents with traumatic brain injury. 
  • 1999 plenary session: Friday imaging symposium : evaluation of focal pulmonary abnormalities with FDG PET. 
  • 2-[18F]F-A-85380: PET imaging of brain nicotinic acetylcholine receptors and whole body distribution in humans. 
  • 2-[18F]F-A-85380: a PET radioligand for alpha4beta2 nicotinic acetylcholine receptors. 
  • 5-substituted derivatives of 6-halogeno-3-((2-(S)-azetidinyl)methoxy)pyridine and 6-halogeno-3-((2-(S)-pyrrolidinyl)methoxy)pyridine with low picomolar affinity for alpha4beta2 nicotinic acetylcholine receptor and wide range of lipophilicity: potential probes for imaging with positron emission tomography. 
  • 6-[18F]fluoro-A-85380, a novel radioligand for in vivo imaging of central nicotinic acetylcholine receptors. 
  • A case-controlled study of 18-fluorodeoxyglucose positron emission tomography in the detection of pelvic recurrence in previously irradiated rectal cancer patients. 
  • A comparison of mechanical and laser transmyocardial revascularization for induction of angiogenesis and arteriogenesis in chronically ischemic myocardium. 
  • A confrontational naming task produces congruent increases and decreases in PET and fMRI. 
  • A default mode of brain function. 
  • A novel silicon array designed for intraoperative charged particle imaging. 
  • Absence of selective deep white matter ischemia in chronic carotid disease: a positron emission tomographic study of regional oxygen extraction. 
  • Accuracy of registration of PET, SPECT and MR images of a brain phantom. 
  • Accuracy of surface fit registration for PET and MR brain images using full and incomplete brain surfaces. 
  • Activation of human medial prefrontal cortex during autonomic responses to hypoglycemia. 
  • Adult age differences in regional cerebral blood flow during visual world identification: evidence from H215O PET. 
  • Adult age differences in the functional neuroanatomy of verbal recognition memory. 
  • Adult age differences in visual word identification: functional neuroanatomy by positron emission tomography. 
  • Age-related differences in effective neural connectivity during encoding and recall. 
  • Age-related differences in neural activity during item and temporal-order memory retrieval: a positron emission tomography study. 
  • Age-related differences in neural activity during memory encoding and retrieval: a positron emission tomography study. 
  • Aging and attentional guidance during visual search: functional neuroanatomy by positron emission tomography. 
  • Aging and recognition memory: changes in regional cerebral blood flow associated with components of reaction time distributions. 
  • Aging gracefully: compensatory brain activity in high-performing older adults. 
  • Alzheimer disease: operating characteristics of PET--a meta-analysis. 
  • An experimental model of chronic myocardial hibernation. 
  • An overview of a camera-based SPECT system. 
  • An overview of imaging techniques and physical aspects of treatment planning in radioimmunotherapy. 
  • Analytical versus voxelized phantom representation for Monte Carlo simulation in radiological imaging. 
  • Attenuation correction in hybrid positron emission tomography. 
  • Automated Talairach atlas labels for functional brain mapping. 
  • Blinded clinical evaluation of positron emission tomography for diagnosis of probable Alzheimer's disease. 
  • Blood-to-brain glucose transport and cerebral glucose metabolism are not reduced in poorly controlled type 1 diabetes. 
  • Blood-to-brain glucose transport, cerebral glucose metabolism, and cerebral blood flow are not increased after hypoglycemia. 
  • Brain morphological changes and early marijuana use: a magnetic resonance and positron emission tomography study. 
  • Brain phantom: high-resolution imaging with SPECT and I-123. 
  • Brain regions differentially involved in remembering what and when: a PET study. 
  • Brief inhalation method to measure cerebral oxygen extraction fraction with PET: accuracy determination under pathologic conditions. 
  • Calculation of attenuation factors from combined singles and coincidence emission projections. 
  • Candidate neuroanatomic substrates of psychosis in old-aged depression. 
  • Cerebellar activity and disturbed time sense after THC. 
  • Cerebral blood flow and cerebral metabolic rate of oxygen requirements for cerebral function and viability in humans. 
  • Cerebral blood flow and metabolism in newborn infants. What can they teach us about stroke? 
  • Cerebral blood flow changes during sodium-lactate-induced panic attacks. 
  • Cerebral blood flow requirement for brain viability in newborn infants is lower than in adults. 
  • Cerebral blood volume measured with inhaled C15O and positron emission tomography. 
  • Cerebral glucose transport and metabolism in preterm human infants. 
  • Cerebral hemodynamic and metabolic changes caused by brain retraction after aneurysmal subarachnoid hemorrhage. 
  • Cerebral hemodynamics in ischemic cerebrovascular disease. 
  • Cerebral imaging of decompression injury patients with 18-F-2-fluoro-2-deoxyglucose positron emission tomography. 
  • Cerebral metabolic and cognitive decline in persons at genetic risk for Alzheimer's disease. 
  • Cerebral oxygen metabolism after aneurysmal subarachnoid hemorrhage. 
  • Cerebral oxygen metabolism in newborns. 
  • Cerebral transport and metabolism of 1-11C-D-glucose during stepped hypoglycemia. 
  • Challenges and opportunities for in vivo imaging in oncology. 
  • Clinical applications of PET in oncology. 
  • Clinical immunotherapy for brain tumors. 
  • Clinical oncologic positron emission tomography: an introduction. 
  • Clinical results of extracranial-intracranial bypass surgery in patients with hemodynamic cerebrovascular disease. 
  • Clinical significance of perfusion defects by thallium-201 single photon emission tomography following oral dipyridamole early after coronary angioplasty. 
  • Clinical utility of positron emission tomography in the diagnosis and management of periampullary neoplasms. 
  • Clinical, 18F-dopa PET, and genetic analysis of an ethnic Chinese kindred with early-onset parkinsonism and parkin gene mutations. 
  • Cognitive neuroscience of aging: contributions of functional neuroimaging. 
  • Coincidence imaging with a dual-head scintillation camera. 
  • Colocalization of gadolinium-diethylene triamine pentaacetic acid with high-molecular-weight molecules after intracerebral convection-enhanced delivery in humans. 
  • Common prefrontal activations during working memory, episodic memory, and semantic memory. 
  • Comparative electrophysiological and hemodynamic measures of neural activation during memory-retrieval. 
  • Comparing MRS and PET. 
  • Comparison of 180 degrees and 360 degrees data collection in thallium-20 1 imaging using single-photon emission computerized tomography (SPECT): concise communication. 
  • Comparison of PET oxygen extraction fraction methods for the prediction of stroke risk. 
  • Comparison of [18 F]fluorocholine and [18 F]fluorodeoxyglucose for positron emission tomography of androgen dependent and androgen independent prostate cancer. 
  • Comparison of functional MR and H2 15O positron emission tomography in stimulation of the primary visual cortex. 
  • Comparison of serial PET and MRI scans in a pediatric patient with a brainstem glioma. 
  • Comparison of whole-body FDG-PET to bone scan for detection of bone metastases in patients with a new diagnosis of lung cancer. 
  • Compensatory mechanisms for chronic cerebral hypoperfusion in patients with carotid occlusion. 
  • Computed tomography of primary liver tumors in children. 
  • Concentration of Tc-99m methylenediphosphonate in hepatic metastases from squamous cell carcinoma. 
  • Cone beam SPECT reconstruction with camera tilt. 
  • Cone beam collimation for single photon emission computed tomography: analysis, simulation, and image reconstruction using filtered backprojection. 
  • Contemporary pediatric thoracic imaging. 
  • Convergence of the maximum likelihood reconstruction algorithm for emission computed tomography. 
  • Correction for partial volume effects in regional blood flow measurements adjacent to hematomas in humans with intracerebral hemorrhage: implementation and validation. 
  • Correlation of FDG-PET imaging with Glut-1 and Glut-3 expression in early-stage non-small cell lung cancer. 
  • Correlation of hippocampal neuronal density and FDG-PET in mesial temporal lobe epilepsy. 
  • Cost-effectiveness analysis of therapy for symptomatic carotid occlusion: PET screening before selective extracranial-to-intracranial bypass versus medical treatment. 
  • Cost-effectiveness of alternative management strategies for patients with solitary pulmonary nodules. 
  • Count-based PET method for predicting ischemic stroke in patients with symptomatic carotid arterial occlusion. 
  • Criteria for termination of phase II chemotherapy for patients with progressive or recurrent brain tumor. 
  • De-novo cholangiocarcinoma in the setting of recurrent primary sclerosing cholangitis following liver transplant. 
  • Deconvolution of Compton scatter in SPECT. 
  • Dedifferentiated parosteal osteosarcoma with giant cell tumor component. 
  • Detection of primary and recurrent lung cancer by means of F-18 fluorodeoxyglucose positron emission tomography (FDG PET). 
  • Detection of pulmonary emboli in dogs: comparison of single photon emission computed tomography, gamma camera imaging, and angiography. 
  • Development of biologic markers of response and assessment of antiangiogenic activity in a clinical trial of human recombinant endostatin. 
  • Development of ligands for in vivo imaging of cerebral nicotinic receptors. 
  • Diagnosing organic mental disorders in the elderly. 
  • Diagnosis of pancreatic carcinoma: role of FDG PET. 
  • Diagnosis of pulmonary embolism. 
  • Differentiation of central nervous system lesions in AIDS patients using positron emission tomography (PET). 
  • Dissociating top-down attentional control from selective perception and action. 
  • Dynamic measurements of local blood flow and metabolism in the study of higher cortical function in humans with positron emission tomography. 
  • Early detection of Alzheimer's disease by combining apolipoprotein E and neuroimaging. 
  • Early recognition of Alzheimer's disease: what is consensual? What is controversial? What is practical? 
  • Echocardiography for the assessment of myocardial viability. 
  • Effect of stepped hypoglycemia on regional cerebral blood flow response to physiological brain activation. 
  • Energy and spatial distribution of multiple order Compton scatter in SPECT: a Monte Carlo investigation. 
  • Episodic memory and the self in a case of isolated retrograde amnesia. 
  • Estimation of myocardial blood flow for longitudinal studies with 13N-labeled ammonia and positron emission tomography. 
  • Evaluation of adrenal masses in patients with bronchogenic carcinoma using 18F-fluorodeoxyglucose positron emission tomography. 
  • Evaluation of hemispheric dominance for language using functional MRI: a comparison with positron emission tomography. 
  • Evaluation of patients with round atelectasis using 2-[18F]-fluoro-2-deoxy-D-glucose PET. 
  • Evaluation of primary pulmonary carcinoid tumors using FDG PET. 
  • Experimental detection of iron overload in liver through neutron stimulated emission spectroscopy. 
  • Extracranial-intracranial bypass surgery: hemodynamic and metabolic effects. 
  • FDG PET imaging in patients with pathologically verified dementia. 
  • FDG PET of pleural effusions in patients with non-small cell lung cancer. 
  • FDG imaging of lung nodules: a phantom study comparing SPECT, camera-based PET, and dedicated PET. 
  • FDG-PET finding in early-phase Takayasu arteritis. 
  • FDG-PET imaging in patients with paraneoplastic syndromes and suspected small cell lung cancer. 
  • FDG-PET in differentiating lymphoma from nonmalignant central nervous system lesions in patients with AIDS. 
  • FDG-PET in pediatric posterior fossa brain tumors. 
  • FDG-PET in the selection of brain lesions for biopsy. 
  • FDG-PET sensitivity for melanoma lymph node metastases is dependent on tumor volume. 
  • False-negative findings for primary lung tumors on FDG positron emission tomography: staging and prognostic implications. 
  • Feasibility of estimating the temperature distribution in a tumor heated by a waveguide applicator. 
  • Fluorine-18 labeled chemotactic peptides: a potential approach for the PET imaging of bacterial infection. 
  • Fluorine-18-antimyosin monoclonal antibody fragments: preliminary investigations in a canine myocardial infarct model. 
  • Fluorine-18-labeled monoclonal antibody fragments: a potential approach for combining radioimmunoscintigraphy and positron emission tomography. 
  • Focal cerebral metabolic abnormality in a patient with continuous spike waves during slow-wave sleep. 
  • Focal features in West syndrome indicating candidacy for surgery. 
  • Focal pulmonary abnormalities: evaluation with F-18 fluorodeoxyglucose PET scanning. 
  • Fortuitous detection of papillary carcinoma of the thyroid with F-18 FDG positron emission tomography in a patient with non-Hodgkin lymphoma. 
  • Fully Bayesian estimation of Gibbs hyperparameters for emission computed tomography data. 
  • Fully three-dimensional positron emission tomography. 
  • Functional Reorganization of Memory after Traumatic Brain Injury: A Study with H2O Positron Emission Tomography 
  • Functional brain maps of retrieval mode and recovery of episodic information. 
  • Functional imaging in lung cancer. 
  • Functional neuroimaging of memory. 
  • Functional neuroimaging of memory: implications for cognitive aging. 
  • Fundamental concepts in myocardial viability assessment revisited: when knowing how much is "alive" is not enough. 
  • Gangliogliomas: characterization by registered positron emission tomography-MR images. 
  • Gastrointestinal bleeding in adult patients with Meckel's diverticulum: the role of technetium 99m pertechnetate scan. 
  • General and specific brain regions involved in encoding and retrieval of events: what, where, and when. 
  • Graphical analysis of 2-[18F]FA binding to nicotinic acetylcholine receptors in rhesus monkey brain. 
  • Hemispheric asymmetry reduction in older adults: the HAROLD model. 
  • Hemodynamic and electrophysiological study of the role of the anterior cingulate in target-related processing and selection for action. 
  • Hemodynamic effects of middle cerebral artery stenosis and occlusion. 
  • Hemodynamics and metabolism in ischemic cerebrovascular disease. 
  • Home surveillance program prevents interstage mortality after the Norwood procedure. 
  • Human herpesvirus 6 limbic encephalitis after stem cell transplantation. 
  • Human pathologic correlation with PET in ischemic and nonischemic cardiomyopathy. 
  • Hyperventilation. 
  • Hypoperfusion without ischemia surrounding acute intracerebral hemorrhage. 
  • Identification of early recurrence of primary central nervous system tumors by [18F]fluorodeoxyglucose positron emission tomography. 
  • Imaging bronchogenic carcinoma. 
  • Imaging cognition II: An empirical review of 275 PET and fMRI studies. 
  • Imaging drug resistance with radiolabeled molecules. 
  • Imaging genotyping of functional signaling pathways in lung squamous cell carcinoma using a radiomics approach. 
  • Imaging lung cancer. 
  • Imaging of brain tumors after administration of L-(N-13)glutamate: concise communication. 
  • Imaging of mediastinal lymph nodes: CT, MR, and FDG PET. 
  • Imaging of pheochromocytoma in 2 dogs using p-[18F] fluorobenzylguanidine. 
  • Imaging of the chest. 
  • Impact of Diabetes Mellitus on the Evaluation of Stable Chest Pain Patients: Insights From the PROMISE (Prospective Multicenter Imaging Study for Evaluation of Chest Pain) Trial. 
  • Impact of computed tomography-positron emission tomography fusion in staging patients with thoracic malignancies. 
  • Importance of hemodynamic factors in the prognosis of symptomatic carotid occlusion. 
  • Improved SPECT quantification using compensation for scattered photons. 
  • Improved perfusion and contractile reserve after transmyocardial laser revascularization in a model of hibernating myocardium. 
  • Improved synthesis of 1-[11C]D-glucose. 
  • Improved synthesis of N-succinimidyl 4-[18F]fluorobenzoate and its application to the labeling of a monoclonal antibody fragment. 
  • In vivo amyloid imaging in Alzheimer's disease. 
  • In vivo imaging of gene expression. 
  • In vivo measurement of regional brain tissue pH using positron emission tomography. 
  • In vivo quantitation of regional cerebral blood flow in glioma and cerebral infarction: validation of the HIPDm-SPECT method. 
  • Incorporation of a left ventricle finite element model defining infarction into the XCAT imaging phantom. 
  • Induction of angiogenesis after TMR: a comparison of holmium: YAG, CO2, and excimer lasers. 
  • Influence of cerebral hemodynamics on stroke risk: one-year follow-up of 30 medically treated patients. 
  • Instrumentation for single-photon-emission computed tomographic studies of the brain. 
  • Interpretation variability of 18FDG-positron emission tomography studies in dementia. 
  • Intersubject variability in cortical activations during a complex language task. 
  • Intersubject variability of functional areas in the human visual cortex. 
  • Interventions for mild cognitive impairment and Alzheimer disease: new strategies, new hope. 
  • Intramyocardial and intracoronary basic fibroblast growth factor in porcine hibernating myocardium: a comparative study. 
  • Introduction to PET Instrumentation. 
  • Introduction to PET instrumentation. 
  • Introduction to neutron stimulated emission computed tomography. 
  • Introduction to the AJR Technology Forum: issues, controversies & utility of PET/CT imaging. 
  • Inverse Monte Carlo as a unified reconstruction algorithm for ECT. 
  • Iodine-131-labeled antitenascin monoclonal antibody 81C6 treatment of patients with recurrent malignant gliomas: phase I trial results. 
  • Ischemic hibernating myocardium demonstrated by positron emission tomography in anomalous origin of the left coronary artery from the pulmonary artery. 
  • Lack of correlation between pattern of collateralization and misery perfusion in patients with carotid occlusion. 
  • Large scale neurocognitive networks underlying episodic memory. 
  • Lateralization of prefrontal activity during episodic memory retrieval: evidence for the production-monitoring hypothesis. 
  • Lesion detection with single-photon emission computed tomography (SPECT) compared with conventional imaging. 
  • Lexical and sublexical components of age-related changes in neural activation during visual word identification. 
  • Limbic encephalitis: comparison of FDG PET and MR imaging findings. 
  • Local recurrence of rectal cancer: evaluation with F-18 fluorodeoxyglucose PET imaging. 
  • Localization of fluorine-18-labeled Mel-14 monoclonal antibody F(ab')2 fragment in a subcutaneous xenograft model. 
  • Locally increased uptake of fluorine-18-fluorodeoxyglucose after intracavitary administration of iodine-131-labeled antibody for primary brain tumors. 
  • Location of the ureters in relation to the uterine cervix by computed tomography. 
  • Lung cancer and positron emission tomography with fluorodeoxyglucose. 
  • Lung tumor growth correlates with glucose metabolism measured by fluoride-18 fluorodeoxyglucose positron emission tomography. 
  • MR and positron emission tomography in the diagnosis of surgically correctable temporal lobe epilepsy. 
  • Magnetic resonance imaging using deoxyhemoglobin contrast versus positron emission tomography in the assessment of brain function. 
  • Marijuana intoxication and brain activation in marijuana smokers. 
  • Measurement of cerebral blood flow in chronic carotid occlusive disease: comparison of dynamic susceptibility contrast perfusion MR imaging with positron emission tomography. 
  • Melanoma patients evaluated by four different positron emission tomography reconstruction techniques. 
  • Mirror movements complicate interpretation of cerebral activation changes during recovery from subcortical infarction. 
  • Monitoring of neoadjuvant therapy response of soft-tissue and musculoskeletal sarcoma using fluorine-18-FDG PET. 
  • Monte Carlo evaluation of Compton scatter subtraction in single photon emission computed tomography. 
  • Multimodality nuclear medicine imaging in three-dimensional radiation treatment planning for lung cancer: challenges and prospects. 
  • Multiplexed protein profiling after aneurysmal subarachnoid hemorrhage: characterization of differential expression patterns in cerebral vasospasm. 
  • Myocardial hibernation and stunning: still much to learn. 
  • National Cancer Institute Workshop statement. Advances in clinical imaging using positron emission tomography, September 14-16, 1988. The Workshop Panel. 
  • Neovascularization after transmyocardial laser revascularization in a model of chronic ischemia. 
  • Network analysis of positron emission tomography regional cerebral blood flow data: ensemble inhibition during episodic memory retrieval. 
  • Neural bases of learning and memory: functional neuroimaging evidence. 
  • Neuroimaging and early diagnosis of Alzheimer disease: a look to the future. 
  • Neuronal migration disorders: positron emission tomography correlations. 
  • Neutron-stimulated emission computed tomography of a multi-element phantom. 
  • No reduction in cerebral metabolism as a result of early moderate hyperventilation following severe traumatic brain injury. 
  • No-carrier-added iodine-131-FIBG: evaluation of an MIBG analog. 
  • Noise characteristics for cone beam collimators: a comparison with parallel hole collimator. 
  • Non-small cell lung cancer: FDG PET for nodal staging in patients with stage I disease. 
  • Non-small cell lung cancer: FDG-PET imaging. 
  • Noninvasive staging of non-small cell lung cancer: a review of the current evidence. 
  • Nonisotropic attenuation in SPECT: phantom tests of quantitative effects and compensation techniques. 
  • Normal brain F-18 FDG-PET and MRI anatomy. 
  • Opportunities for improvement on current nuclear cardiology practices and radiation exposure in Latin America: Findings from the 65-country IAEA Nuclear Cardiology Protocols cross-sectional Study (INCAPS). 
  • Overview of functional imaging. 
  • PET concerns in bevacizumab treatment. 
  • PET imaging in patients with bronchioloalveolar cell carcinoma. 
  • PET imaging of osteosarcoma in dogs using a fluorine-18-labeled monoclonal antibody Fab fragment. 
  • PET screening of carotid occlusion. 
  • PET studies of the influences of nicotine on neural systems in cigarette smokers. 
  • PET: the new focus of nuclear medicine? 
  • Pain, PSA flare, and bone scan response in a patient with metastatic castration-resistant prostate cancer treated with radium-223, a case report. 
  • Para-[18F]fluorobenzylguanidine kinetics in a canine coronary artery occlusion model. 
  • Patterns and predictors of stress testing modality after percutaneous coronary stenting: data from the NCDR(®). 
  • Performance characteristics of a whole-body PET scanner. 
  • Performance of dedicated emission mammotomography for various breast shapes and sizes. 
  • Performance standards in positron emission tomography. 
  • Perineural spread of melanoma demonstrated by F-18 FDG PET With MRI and pathologic correlation. 
  • Persistent or recurrent bronchogenic carcinoma: detection with PET and 2-[F-18]-2-deoxy-D-glucose. 
  • Pharmacokinetics and radiation dosimetry of 18F-fluorocholine. 
  • Phase I trial results of iodine-131-labeled antitenascin monoclonal antibody 81C6 treatment of patients with newly diagnosed malignant gliomas. 
  • Physical characteristics of SPECT systems, September, 1982. 
  • Physiological responses to focal cerebral ischemia in humans. 
  • Pilot study of positron emission tomography in patients with advanced head and neck cancer receiving radiotherapy and chemotherapy. 
  • Positron emission tomographic imaging with fluorodeoxyglucose isefficacious in evaluating malignant pulmonary disease. 
  • Positron emission tomography and its application to the study of cerebrovascular disease in man. 
  • Positron emission tomography detection of metastatic penile squamous cell carcinoma. 
  • Positron emission tomography for the evaluation of pancreatic disease. 
  • Positron emission tomography imaging in the thorax. 
  • Positron emission tomography imaging of brain tumors. 
  • Positron emission tomography imaging of the thorax. 
  • Positron emission tomography in cerebrovascular disease. 
  • Positron emission tomography in evaluation of dementia: Regional brain metabolism and long-term outcome. 
  • Positron emission tomography in neuropsychiatry. 
  • Positron emission tomography in pediatric epilepsy. 
  • Positron emission tomography in the pretreatment evaluation and follow-up of non-small cell lung cancer patients treated with radiotherapy: preliminary findings. 
  • Positron emission tomography scanning in malignant melanoma. 
  • Positron emission tomography to assess cerebral perfusion. 
  • Positron emission tomography with 2-deoxy-2-[(18)F]fluoro-D-glucose for evaluating local and distant disease in patients with cervical cancer. 
  • Positron emission tomography with fluoro-2-deoxy-D-glucose (FDG-PET) in the staging of post transplant lymphoproliferative disorder in lung transplant recipients. 
  • Positron emission tomography: brain tumors and lung cancer. 
  • Preclinical evaluation and PET imaging of 18F-labeled Mel-14 F(ab')2 fragment in normal dogs. 
  • Predictors of outcome of epilepsy surgery: multivariate analysis with validation. 
  • Preoperative radiation therapy and chemotherapy for pulmonary blastoma: a case report. 
  • Primary muscle lymphoma: clinical and imaging findings. 
  • Prognosis in medically stabilized unstable angina: early Holter ST-segment monitoring compared with predischarge exercise thallium tomography. 
  • Prognostic value of thoracic FDG PET imaging after treatment for non-small cell lung cancer. 
  • Prospective investigation of positron emission tomography in lung nodules. 
  • Pulmonary abnormalities and PET data analysis: a retrospective study. 
  • Quantification of infarct size by 201Tl single-photon emission computed tomography during acute myocardial infarction in humans. Comparison with enzymatic estimates. 
  • Quantification of myocardial perfusion by MRI after coronary occlusion. 
  • Quantitative analysis of biomarkers defines an optimal biological dose for recombinant human endostatin in primary human tumors. 
  • Quantitative measurements of cerebral blood flow in patients with unilateral carotid artery occlusion: a PET and MR study. 
  • Quantitative study of cardiac motion estimation and abnormality classification in emission computed tomography. 
  • Quantitative thallium-201 single photon emission computed tomography after oral dipyridamole for assessing the presence, anatomic location and severity of coronary artery disease. 
  • Radiation absorbed dose estimates for [1-carbon-11]-glucose in adults: the effects of hyperinsulinemia. 
  • Radionuclide viability testing: should it affect treatment strategy in patients with cardiomyopathy and significant coronary artery disease? 
  • Radiosynthesis of 5-(2-(4-pyridinyl)vinyl)-6-chloro-3-(1-[(11)C]methyl-2-(S)-pyrrolidinylmethoxy)pyridine, a high affinity ligand for studying nicotinic acetylcholine receptors by positron emission tomography. 
  • Rasmussen's encephalitis: neuroimaging findings in four patients. 
  • Regional brain activation in response to rectal distension in patients with irritable bowel syndrome and the effect of a history of abuse. 
  • Regional cerebral blood flow and depersonalization after tetrahydrocannabinol administration. 
  • Regional cerebrovascular and metabolic effects of hyperventilation after severe traumatic brain injury. 
  • Research and clinical potential of receptor based radiopharmaceuticals. 
  • Results of the American College of Surgeons Oncology Group Z0050 trial: the utility of positron emission tomography in staging potentially operable non-small cell lung cancer. 
  • Reversible neurotoxicity following hyperfractionated radiation therapy of brain stem glioma. 
  • SPECT quantification of technetium-99m microspheres within the canine lung. 
  • SPECT using a specially designed cone beam collimator. 
  • Sarcoma tumor FDG uptake measured by PET and patient outcome: a retrospective analysis. 
  • Scatter detection in SPECT imaging: dependence on source depth, energy, and energy window. 
  • Screening for cerebral metastases with FDG PET in patients undergoing whole-body staging of non-central nervous system malignancy. 
  • Semiquantitative and visual analysis of FDG-PET images in pulmonary abnormalities. 
  • Sequential preoperative fluorodeoxyglucose-positron emission tomography assessment of response to preoperative chemoradiation: a means for determining longterm outcomes of rectal cancer. 
  • Severe hemodynamic impairment and border zone--region infarction. 
  • Single photon emission computed tomography (SPECT). Part II: Clinical applications. 
  • Single photon emission computed tomography (SPECT). Principles and instrumentation. 
  • Single-photon-emission computed tomographic imaging of glioma. 
  • Small-animal PET: advent of a new era of PET research. 
  • Solitary pulmonary nodules: Part I. Morphologic evaluation for differentiation of benign and malignant lesions. 
  • Solitary pulmonary nodules: Part II. Evaluation of the indeterminate nodule. 
  • Specific and high-level targeting of radiolabeled octreotide analogues to human medulloblastoma xenografts. 
  • Squamous cell carcinoma of the palatine tonsils: FDG standardized uptake value ratio as a biomarker to differentiate tonsillar carcinoma from physiologic uptake. 
  • Staging non-small cell lung cancer with whole-body PET. 
  • Staging techniques for lung cancer. 
  • Standardized tests of PET performance. 
  • Steady-state fluorescence imaging of neoplasia. 
  • Structure--function spatial covariance in the human visual cortex. 
  • Studying regional brain function: a challenge for SPECT. 
  • Surgical outcome in patients with epilepsy with occult vascular malformations treated with lesionectomy. 
  • Synthesis and evaluation of (18)F-labeled choline analogs as oncologic PET tracers. 
  • Synthesis and evaluation of 18F-labeled choline as an oncologic tracer for positron emission tomography: initial findings in prostate cancer. 
  • Synthesis and evaluation of a novel series of 2-chloro-5-((1-methyl-2-(S)-pyrrolidinyl)methoxy)-3-(2-(4-pyridinyl)vinyl)pyridine analogues as potential positron emission tomography imaging agents for nicotinic acetylcholine receptors. 
  • Synthesis and preliminary evaluation of para- and meta-[18F]fluorobenzylguanidine. 
  • Synthesis, structure-activity relationship, and evaluation of SR141716 analogues: development of central cannabinoid receptor ligands with lower lipophilicity. 
  • T1 lung cancers: sensitivity of diagnosis with fluorodeoxyglucose PET. 
  • Talc pleurodesis simulating pleural metastases on 18F-fluorodeoxyglucose positron emission tomography. 
  • Task-related and item-related brain processes of memory retrieval. 
  • Tc-99m attenuation coefficients in water-filled phantoms determined with gamma cameras. 
  • Technology assessment revisited: does positron emission tomography have proven clinical efficacy? 
  • Temporal lobe hypometabolism on PET: predictor of seizure control after temporal lobectomy. 
  • The effect of carotid artery disease on the cerebrovascular response to physiologic stimulation. 
  • The effect of divided attention on encoding and retrieval in episodic memory revealed by positron emission tomography. 
  • The effect of metabolic milieu on cardiac PET imaging using fluorine-18-deoxyglucose and nitrogen-13-ammonia in normal volunteers. 
  • The effects of divided attention on encoding- and retrieval-related brain activity: A PET study of younger and older adults. 
  • The neural correlates of intentional learning of verbal materials: a PET study in humans. 
  • The prognostic significance of fluorodeoxyglucose positron emission tomography imaging for patients with nonsmall cell lung carcinoma. 
  • The role of F-18 FDG positron emission tomography in preoperative assessment of the liver in patients being considered for curative resection of hepatic metastases from colorectal cancer. 
  • The role of PET scanning in the detection of recurrent cervical cancer. 
  • The role of imaging in malignant pleural mesothelioma. 
  • The temporal dynamics of the effects in occipital cortex of visual-spatial selective attention. 
  • The use of positron emission tomography in cerebrovascular disease. 
  • Therapeutic angiogenesis in chronically ischemic porcine myocardium: comparative effects of bFGF and VEGF. 
  • Thoracic FDG PET: state of the art. 
  • Thoracic nodal staging with PET imaging with 18FDG in patients with bronchogenic carcinoma. 
  • Three-dimensional imaging of whole rodent organs using optical computed and emission tomography. 
  • Time course of tetrahydrocannabinol-induced changes in regional cerebral blood flow measured with positron emission tomography. 
  • Tl-201 single-photon emission computed tomography (SPECT). 
  • Usefulness of positron emission tomography in evaluating dementia. 
  • Utility of Radionuclide Bone Scintigraphy in Complex Regional Pain Syndrome. 
  • Validation of 4-[fluorine-18]fluoro-3-iodobenzylguanidine as a positron-emitting analog of MIBG. 
  • Variability of cerebral blood volume and oxygen extraction: stages of cerebral haemodynamic impairment revisited. 
  • When should functional neuroimaging techniques be used in the diagnosis and management of Alzheimer's dementia? A decision analysis. 
  • Whole-body single-photon emission computed tomography using dual, large-field-of-view scintillation cameras. 
  • Work in progress: [18F] fluorodeoxyglucose and positron emission tomography in the evaluation of radiation necrosis of the brain. 
  • [18F]2-fluoro-2-deoxyglucose-positron emission tomography correlation of gadolinium-enhanced MR imaging of central nervous system neoplasia. 
  • [Computed tomography with thallium-201 and oral dipyridamole in the diagnosis of coronary artery disease]. 
  • [Rubral tremor of Holmes, rare case of pathological tremor: case report]. 
• 

  Keywords of People

  • Berchuck, Andrew, James M. Ingram Distinguished Professor of Gynecologic Oncology, Obstetrics and Gynecology, Gynecologic Oncology
  • Charles, Hal Cecil, Adjunct Associate Professor in the Department of Radiology, Radiology
  • Colsher, James George, Adjunct Assistant Professor in the Department of Radiology, Radiology
  • McLendon, Roger Edwin, Professor of Pathology, Pathology
  • O'Connor, Christopher Michael, Adjunct Professor in the Department of Medicine, Medicine, Clinical Pharmacology
  • Patz Jr., Edward F., James and Alice Chen Distinguished Professor of Radiology, Pathology
  • Roy Choudhury, Kingshuk, Adjunct Associate Professor in the Department of Biostatistics & Bioinformatics, Biostatistics & Bioinformatics
  • Sampson, John Howard, Robert H., M.D. and Gloria Wilkins Professor of Neurosurgery, in the School of Medicine, Biomedical Engineering
  • Segars, William Paul, Associate Professor in Radiology, Radiology
  • Turkington, Timothy Garvey, Associate Professor in Radiology, Radiology